Target intelligence / Profile preview

Actin, aortic smooth muscle (ACTA2)

Target
ACTA2
Molecular classification
Other
01

Overview

Actin, aortic smooth muscle (encoded by the ACTA2 gene) is a highly conserved cytoskeletal protein that belongs to the actin family and serves as a major component of the contractile apparatus in vascular smooth muscle cells (VSMCs). It plays a critical role in maintaining vascular tone, blood pressure homeostasis, and the structural integrity of blood vessels. Beyond its physiological role in smooth muscle contraction, ACTA2 is a well-established marker of myofibroblast differentiation and is highly expressed in activated cancer-associated fibroblasts (CAFs), where it contributes to stromal remodeling, tissue fibrosis, and tumor progression. Mutations in the ACTA2 gene, such as the severe R179H variant, disrupt actin filament assembly and lead to life-threatening conditions like familial thoracic aortic aneurysm and dissection (TAAD), early-onset stroke, Moyamoya disease, and multisystemic smooth muscle dysfunction syndrome (SMDS).

Therapeutically, ACTA2 is targeted through novel genetic approaches, including bespoke CRISPR-Cas9 base editors and lipid nanoparticle (LNP) or adeno-associated virus (AAV) gene therapies designed to correct pathogenic mutations directly within the vasculature. Additionally, repurposed metabolic therapies like sapropterin and nicotinamide riboside are being evaluated to improve smooth muscle cell function and reduce vascular complications. In oncology, ACTA2 serves as a key biomarker for predicting resistance to therapies like trastuzumab and monitoring glioma recurrence, making it a high-value target for both diagnostic and therapeutic interventions.

Other names
Alpha-smooth muscle actinα-SMAAlpha-actin-2Aortic smooth muscle actinACTSAACTVSGIG46Cell growth-inhibiting gene 46 protein
02

Mechanism of action

Direct genomic correction of pathogenic ACTA2 variants using CRISPR-Cas9 base editors or gene therapy; metabolic support and improvement of smooth muscle cell function via sapropterin or nicotinamide riboside; downregulation of expression using siRNA/miRNA; downstream inhibition of contractility and stress fiber formation via ROCK inhibitors.

03

Biological functions

Cell motilityMuscle contractionVascular contractilityBlood pressure homeostasisMyofibroblast differentiationOther
04

Disease associations

Cardiovascular diseaseCancerOther
05

Safety considerations

Systemic smooth muscle dysfunction (hypotonic bladder, congenital mydriasis, intestinal hypoperistalsis)Vascular instability and increased risk of thoracic aortic aneurysm or dissectionOff-target genomic editing or bystander mutationsImpaired wound healing and tissue repair
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

Alpha-smooth muscle actin (α-SMA) expressionACTA2 gene mutations (e.g., R179H)

Beyond the preview

Go deeper on Actin, aortic smooth muscle (ACTA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin, aortic smooth muscle (ACTA2).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call